ABCA7 and Alzheimer disease: According to De Roeck et al. [58], a possible explanation for these opposite observations could be that decreased ABCA7 may contribute to AD pathology in the early stages of the disease; however, it is possible that at later stages, ABCA7 is upregulated as a compensatory mechanism in AD brains.